| | | | | | | | | | | | | | | | |
| | |
 | Issue Date FY: 2023 ( Subtotal = $9,317,308 ) |
| | 2023 | 2023 | LA JOLLA INSTITUTE FOR IMMUNOLOGY | 9420 ATHENA CIR | LA JOLLA | CA | 92037-1387 | SAN DIEGO | USA | U01AI141995 | Identifying mechanisms and correlates of long-lasting vaccine-induced immunity to whooping cough | 003 | 5 | NIH | 11/2/2022 | $823,202 |
| | 2023 | 2023 | LA JOLLA INSTITUTE FOR IMMUNOLOGY | 9420 ATHENA CIR | LA JOLLA | CA | 92037-1387 | SAN DIEGO | USA | R01AI139749 | CD4 T cell control of cytomegalovirus | 000 | 5 | NIH | 12/21/2022 | $565,653 |
| | 2023 | 2023 | LA JOLLA INSTITUTE FOR IMMUNOLOGY | 9420 ATHENA CIR | LA JOLLA | CA | 92037-1387 | SAN DIEGO | USA | R01CA233862 | A Treg cell-intrinsic CTLA4-PKC-eta signaling pathway mediating contact-dependent suppression of tumor immunity: A novel target for cancer immunotherapy | 000 | 5 | NIH | 11/17/2022 | $470,757 |
| | 2023 | 2023 | LA JOLLA INSTITUTE FOR IMMUNOLOGY | 9420 ATHENA CIR | LA JOLLA | CA | 92037-1387 | SAN DIEGO | USA | R01AI153500 | Maternal Antibody-Mediated Enhancement of Dengue Pathogenesis | 000 | 3 | NIH | 1/27/2023 | $568,385 |
| | 2023 | 2023 | LA JOLLA INSTITUTE FOR IMMUNOLOGY | 9420 ATHENA CIR | LA JOLLA | CA | 92037-1387 | SAN DIEGO | USA | R37AI125068 | Maximizing germinal centers and somatic hypermutation to HIV Env immunogens | 000 | 8 | NIH | 1/4/2023 | $869,654 |
| | 2023 | 2023 | LA JOLLA INSTITUTE FOR IMMUNOLOGY | 9420 ATHENA CIR | LA JOLLA | CA | 92037-1387 | SAN DIEGO | USA | U19AI142742 | Functional and dysfunctional human CD4 T cell and B cell responses to bacteria and viruses | 001 | 5 | NIH | 3/14/2023 | $2,713,421 |
| | 2023 | 2023 | LA JOLLA INSTITUTE FOR IMMUNOLOGY | 9420 ATHENA CIR | LA JOLLA | CA | 92037-1387 | SAN DIEGO | USA | R01CA233862 | A Treg cell-intrinsic CTLA4-PKC-eta signaling pathway mediating contact-dependent suppression of tumor immunity: A novel target for cancer immunotherapy | 001 | 5 | NIH | 3/16/2023 | $41,844 |
| | 2023 | 2023 | LA JOLLA INSTITUTE FOR IMMUNOLOGY | 9420 ATHENA CIR | LA JOLLA | CA | 92037-1387 | SAN DIEGO | USA | R01DK135683 | Genetic studies linking LSP1 function in T cells to Inflammatory Bowel Disease | 000 | 1 | NIH | 3/6/2023 | $402,600 |
| | 2023 | 2023 | LA JOLLA INSTITUTE FOR IMMUNOLOGY | 9420 ATHENA CIR | LA JOLLA | CA | 92037-1387 | SAN DIEGO | USA | U01AI150753 | Developing computational models to predict the immune response to B. pertussis booster vaccination | 000 | 4 | NIH | 2/21/2023 | $1,350,127 |
| | 2023 | 2023 | LA JOLLA INSTITUTE FOR IMMUNOLOGY | 9420 ATHENA CIR | LA JOLLA | CA | 92037-1387 | SAN DIEGO | USA | R01AI143934 | The Role of Cytoplasmic and Nuclear THEMIS in Immature and Mature T cells | 000 | 4 | NIH | 1/16/2023 | $688,446 |
| | 2023 | 2023 | LA JOLLA INSTITUTE FOR IMMUNOLOGY | 9420 ATHENA CIR | LA JOLLA | CA | 92037-1387 | SAN DIEGO | USA | R01AI109842 | NFAT, bZIP proteins, and transcriptional programs in lymphocytes | 000 | 35 | NIH | 2/15/2023 | $842,353 |
| | 2023 | 2022 | LA JOLLA INSTITUTE FOR IMMUNOLOGY | 9420 ATHENA CIR | LA JOLLA | CA | 92037-1387 | SAN DIEGO | USA | U24CA248138 | THE CANCER EPITOPE DATABASE AND ANALYSIS RESOURCE | 000 | 2 | NIH | 12/16/2022 | $0 |
| | 2023 | 2022 | LA JOLLA INSTITUTE FOR IMMUNOLOGY | 9420 ATHENA CIR | LA JOLLA | CA | 92037-1387 | SAN DIEGO | USA | U19AI142742 | Functional and dysfunctional human CD4 T cell and B cell responses to bacteria and viruses | 000 | 4 | NIH | 2/16/2023 | $0 |
| | 2023 | 2022 | LA JOLLA INSTITUTE FOR IMMUNOLOGY | 9420 ATHENA CIR | LA JOLLA | CA | 92037-1387 | SAN DIEGO | USA | U01DE028227 | Stimulating Neo-Antigen Specific T Cell Responses in Head and Neck Cancers | 001 | 5 | NIH | 1/3/2023 | $0 |
| | 2023 | 2022 | LA JOLLA INSTITUTE FOR IMMUNOLOGY | 9420 ATHENA CIR | LA JOLLA | CA | 92037-1387 | SAN DIEGO | USA | U19AI118626 | Respiratory pathogen-specific T cell signatures following vaccination, natural infection, and treatment | 000 | 8 | NIH | 10/21/2022 | $0 |
| | 2023 | 2022 | LA JOLLA INSTITUTE FOR IMMUNOLOGY | 9420 ATHENA CIR | LA JOLLA | CA | 92037-1387 | SAN DIEGO | USA | U19AI142790 | Consortium for Immunotherapeutics against Emerging Viral Threats | 001 | 4 | NIH | 3/1/2023 | $0 |
| | 2023 | 2022 | LA JOLLA INSTITUTE FOR IMMUNOLOGY | 9420 ATHENA CIR | LA JOLLA | CA | 92037-1387 | SAN DIEGO | USA | U19AI142790 | Consortium for Immunotherapeutics against Emerging Viral Threats | 000 | 4 | NIH | 1/24/2023 | $0 |
| | 2023 | 2022 | LA JOLLA INSTITUTE FOR IMMUNOLOGY | 9420 ATHENA CIR | LA JOLLA | CA | 92037-1387 | SAN DIEGO | USA | U01AI141995 | Identifying mechanisms and correlates of long-lasting vaccine-induced immunity to whooping cough | 002 | 4 | NIH | 10/18/2022 | $0 |
| | 2023 | 2022 | LA JOLLA INSTITUTE FOR IMMUNOLOGY | 9420 ATHENA CIR | LA JOLLA | CA | 92037-1387 | SAN DIEGO | USA | U01DE028227 | Stimulating Neo-Antigen Specific T Cell Responses in Head and Neck Cancers | 001 | 5 | NIH | 1/3/2023 | $0 |
| | 2023 | 2021 | LA JOLLA INSTITUTE FOR IMMUNOLOGY | 9420 ATHENA CIR | LA JOLLA | CA | 92037-1387 | SAN DIEGO | USA | U01AI141995 | Identifying mechanisms and correlates of long-lasting vaccine-induced immunity to whooping cough | 001 | 3 | NIH | 10/17/2022 | $0 |
| | 2023 | 2021 | LA JOLLA INSTITUTE FOR IMMUNOLOGY | 9420 ATHENA CIR | LA JOLLA | CA | 92037-1387 | SAN DIEGO | USA | F32AI147531 | Rabies virus glycoprotein structure determination and receptor binding interactions | 001 | 3 | NIH | 11/23/2022 | -$5,714 |
| | 2023 | 2021 | LA JOLLA INSTITUTE FOR IMMUNOLOGY | 9420 ATHENA CIR | LA JOLLA | CA | 92037-1387 | SAN DIEGO | USA | R01AI092453 | Specificity, Phenotype and Function of Pancreatic CD8 T Cells in Human Type 1 Diabetes | 000 | 10 | NIH | 3/23/2023 | $0 |
| | 2023 | 2020 | LA JOLLA INSTITUTE FOR IMMUNOLOGY | 9420 ATHENA CIR | LA JOLLA | CA | 92037-1387 | SAN DIEGO | USA | R21AI145374 | Genetic contributions to T cell mediated immunopathology after viral infection | 000 | 3 | NIH | 11/10/2022 | $0 |
| | 2023 | 2020 | LA JOLLA INSTITUTE FOR IMMUNOLOGY | 9420 ATHENA CIR | LA JOLLA | CA | 92037-1387 | SAN DIEGO | USA | F32AI147531 | Rabies virus glycoprotein structure determination and receptor binding interactions | 000 | 2 | NIH | 11/23/2022 | -$2,847 |
| | 2023 | 2020 | LA JOLLA INSTITUTE FOR IMMUNOLOGY | 9420 ATHENA CIR | LA JOLLA | CA | 92037-1387 | SAN DIEGO | USA | U01AI141995 | Identifying mechanisms and correlates of long-lasting vaccine-induced immunity to whooping cough | 000 | 2 | NIH | 10/14/2022 | $0 |
| | 2023 | 2020 | LA JOLLA INSTITUTE FOR IMMUNOLOGY | 9420 ATHENA CIR | LA JOLLA | CA | 92037-1387 | SAN DIEGO | USA | U01DE028227 | Stimulating Neo-Antigen Specific T Cell Responses in Head and Neck Cancers | 000 | 3 | NIH | 12/6/2022 | $0 |
| | 2023 | 2020 | LA JOLLA INSTITUTE FOR IMMUNOLOGY | 9420 ATHENA CIR | LA JOLLA | CA | 92037-1387 | SAN DIEGO | USA | R01AI123398 | Regulation of innate lymphoid cells in inflammation | 000 | 5 | NIH | 11/22/2022 | $0 |
| | 2023 | 2020 | LA JOLLA INSTITUTE FOR IMMUNOLOGY | 9420 ATHENA CIR | LA JOLLA | CA | 92037-1387 | SAN DIEGO | USA | U01DE028227 | Stimulating Neo-Antigen Specific T Cell Responses in Head and Neck Cancers | 000 | 3 | NIH | 12/6/2022 | $0 |
| | 2023 | 2019 | LA JOLLA INSTITUTE FOR IMMUNOLOGY | 9420 ATHENA CIR | LA JOLLA | CA | 92037-1387 | SAN DIEGO | USA | T32AI125179 | Training in Immunological Mechanisms | 000 | 4 | NIH | 3/17/2023 | -$10,574 |
|
| Issue Date FY: 2022 ( Subtotal = $38,833,201 ) (Continued on the next page) |
| | 2022 | 2022 | LA JOLLA INSTITUTE FOR IMMUNOLOGY | 9420 ATHENA CIR | LA JOLLA | CA | 92037-1387 | SAN DIEGO | USA | U01AI150753 | Developing computational models to predict the immune response to B. pertussis booster vaccination | 000 | 3 | NIH | 2/11/2022 | $1,351,458 |
| | 2022 | 2022 | LA JOLLA INSTITUTE FOR IMMUNOLOGY | 9420 ATHENA CIR | LA JOLLA | CA | 92037-1387 | SAN DIEGO | USA | R01AI109842 | NFAT, bZIP proteins, and transcriptional programs in lymphocytes | 000 | 34 | NIH | 2/28/2022 | $842,353 |
| | 2022 | 2022 | LA JOLLA INSTITUTE FOR IMMUNOLOGY | 9420 ATHENA CIR | LA JOLLA | CA | 92037-1387 | SAN DIEGO | USA | R01AI101423 | The role of TRAIL in immune control of cytomegalovirus | 000 | 9 | NIH | 5/18/2022 | $549,000 |
| | 2022 | 2022 | LA JOLLA INSTITUTE FOR IMMUNOLOGY | 9420 ATHENA CIR | LA JOLLA | CA | 92037-1387 | SAN DIEGO | USA | R01AI040127 | Signal transduction and gene induction in lymphocytes | 000 | 30 | NIH | 8/23/2022 | $540,000 |
| | 2022 | 2022 | LA JOLLA INSTITUTE FOR IMMUNOLOGY | 9420 ATHENA CIR | LA JOLLA | CA | 92037-1387 | SAN DIEGO | USA | R01AI135193 | CD4 T cell, germinal center, and antibody response defects in recurrent tonsillitis | 001 | 5 | NIH | 6/9/2022 | $112,500 |
| | 2022 | 2022 | LA JOLLA INSTITUTE FOR IMMUNOLOGY | 9420 ATHENA CIR | LA JOLLA | CA | 92037-1387 | SAN DIEGO | USA | R01AI135193 | CD4 T cell, germinal center, and antibody response defects in recurrent tonsillitis | 000 | 5 | NIH | 6/2/2022 | $337,500 |
| | 2022 | 2022 | LA JOLLA INSTITUTE FOR IMMUNOLOGY | 9420 ATHENA CIR | LA JOLLA | CA | 92037-1387 | SAN DIEGO | USA | R01AI139749 | CD4 T cell control of cytomegalovirus | 000 | 4 | NIH | 1/13/2022 | $615,063 |
| | 2022 | 2022 | LA JOLLA INSTITUTE FOR IMMUNOLOGY | 9420 ATHENA CIR | LA JOLLA | CA | 92037-1387 | SAN DIEGO | USA | R01CA233862 | A Treg cell-intrinsic CTLA4-PKC-eta signaling pathway mediating contact-dependent suppression of tumor immunity: A novel target for cancer immunotherapy | 001 | 4 | NIH | 6/22/2022 | $41,845 |
| | 2022 | 2022 | LA JOLLA INSTITUTE FOR IMMUNOLOGY | 9420 ATHENA CIR | LA JOLLA | CA | 92037-1387 | SAN DIEGO | USA | R01CA233862 | A Treg cell-intrinsic CTLA4-PKC-eta signaling pathway mediating contact-dependent suppression of tumor immunity: A novel target for cancer immunotherapy | 000 | 4 | NIH | 11/22/2021 | $470,756 |
| | 2022 | 2022 | LA JOLLA INSTITUTE FOR IMMUNOLOGY | 9420 ATHENA CIR | LA JOLLA | CA | 92037-1387 | SAN DIEGO | USA | R01AI134971 | Integrated Functional Histopathology of the Diabetic Human Pancreas | 000 | 5 | NIH | 11/17/2021 | $699,000 |
| | 2022 | 2022 | LA JOLLA INSTITUTE FOR IMMUNOLOGY | 9420 ATHENA CIR | LA JOLLA | CA | 92037-1387 | SAN DIEGO | USA | R01AI128589 | Investigating the role of TET deficiency in promoting T cell expansion and inflammation | 000 | 6 | NIH | 6/7/2022 | $549,000 |
| | 2022 | 2022 | LA JOLLA INSTITUTE FOR IMMUNOLOGY | 9420 ATHENA CIR | LA JOLLA | CA | 92037-1387 | SAN DIEGO | USA | R01CA256133 | Bioactive Metabolites Modulate Immune-Related Adverse Events in Cancer Immunotherapy | 000 | 2 | NIH | 6/28/2022 | $706,425 |
| | 2022 | 2022 | LA JOLLA INSTITUTE FOR IMMUNOLOGY | 9420 ATHENA CIR | LA JOLLA | CA | 92037-1387 | SAN DIEGO | USA | R01CA247500 | Exploring the potential of TET inhibition in cancer immunotherapy | 000 | 3 | NIH | 7/14/2022 | $492,576 |
| | 2022 | 2022 | LA JOLLA INSTITUTE FOR IMMUNOLOGY | 9420 ATHENA CIR | LA JOLLA | CA | 92037-1387 | SAN DIEGO | USA | R01AI163665 | Role of a Novel Interferon Responsive T Cell Subset in Allergy and Asthma | 000 | 1 | NIH | 9/20/2022 | $457,500 |
| | 2022 | 2022 | LA JOLLA INSTITUTE FOR IMMUNOLOGY | 9420 ATHENA CIR | LA JOLLA | CA | 92037-1387 | SAN DIEGO | USA | R01AI163188 | Development of a Replicon RNA-based Vaccine against Dengue and Zika | 000 | 2 | NIH | 5/24/2022 | $712,699 |
| | 2022 | 2022 | LA JOLLA INSTITUTE FOR IMMUNOLOGY | 9420 ATHENA CIR | LA JOLLA | CA | 92037-1387 | SAN DIEGO | USA | S10OD030417 | Automated Multiscale Super-resolution Confocal Microscope | 000 | 1 | NIH | 9/2/2022 | $514,425 |
| | 2022 | 2022 | LA JOLLA INSTITUTE FOR IMMUNOLOGY | 9420 ATHENA CIR | LA JOLLA | CA | 92037-1387 | SAN DIEGO | USA | R35GM147554 | Elucidating the signaling and protein interaction networks of the O-GlcNAc transferase during embryonic stem cell state transitions | 000 | 1 | NIH | 7/4/2022 | $457,500 |
| | 2022 | 2022 | LA JOLLA INSTITUTE FOR IMMUNOLOGY | 9420 ATHENA CIR | LA JOLLA | CA | 92037-1387 | SAN DIEGO | USA | U01AI167892 | HIPC Data Coordinating Center | 002 | 1 | NIH | 9/7/2022 | $419,705 |
| | 2022 | 2022 | LA JOLLA INSTITUTE FOR IMMUNOLOGY | 9420 ATHENA CIR | LA JOLLA | CA | 92037-1387 | SAN DIEGO | USA | U01AI167892 | HIPC Data Coordinating Center | 001 | 1 | NIH | 6/29/2022 | $0 |
|
